Title: Genomic sequences of 2 iconic falconry birds - Peregrine and Saker Falcons- Post by: Donna on 16-Dec-11, 08:43:30 PM Public release date: 16-Dec-2011
liujia@genomics.cn BGI Shenzhen Genomic sequences of 2 iconic falconry birds - Peregrine and Saker Falcons- successfully decoded The complete genomes for birds of prey provide new insight into the evolution of falcon and opportunity for future conservation December 16, 2011, Copenhagen, Denmark, and Shenzhen, China - A group of scientists from United Kingdom (UK), China and United Arab Emirates (UAE) jointly announced the complete sequencing of peregrine and saker falcons genomes at the 2nd International Festival of Falconry held in Al Ain, UAE. The study is a part of Falcon Genome Project, launched and funded by the Environment Agency – Abu Dhabi (EAD) in this January. The results will enable biologists to better study the basic biology and genetics of falcons and provide new insights into understanding the origin and populations of these species. Two particular species of birds, peregrine and saker falcons, are widespread but heavily exploited birds of prey that exhibit migratory habit and are popular hunting falcons commonly found in the country. In particular, the saker is the national bird of United Arab Emirate. In the past century, the two falcons have been listed as endangered species with population decline, caused by a wide range of factors including migration obstacles, environmental changes, habitat loss, use of pesticides (e.g. DDT, PCBs), among others. In the late 1990s, the peregrine has been successfully removed from the endangered species list through the increased recovery efforts, but the saker is still facing this challenge. Since this January, researchers from UK, China and UAE have been working together to conduct the genomic studies of peregrine and saker falcons, aiming to identify the genome sequences of the two species and enhance their future conservation to face the unforeseen challenge of the rapid changing environments and human activities. Abu Dhabi's Falcon Hospital (ADFH) provided the blood samples collected from male specimens of peregrine and saker falcons, and BGI were responsible for sequencing these samples on its large-scale next-generation sequencing platforms and producing high-quality data output. The bioinformatics analysis is conducted by the scientists from the School of Biosciences, Cardiff University (UK) and BGI. Dr. Ning Li, CEO of BGI Europe, said, "The complete genome sequencing of the two falcons will lay a solid scientific foundation for identifying the origin and populations of falcons and accelerating the selective breeding of high-quality varieties. We believe we will make more breakthroughs in this project to help researchers better protect these endangered species." "This study will open the door to an unparalleled understanding of falcon biology and help us to manage and conserve wild falcon stocks in the future" said Dr Andrew Dixon, Head of Research at International Wildlife Consultants Ltd (IWC). ### About BGI BGI was founded in Beijing, China, in 1999 with the mission to become a premier scientific partner for the global research community. The goal of BGI is to make leading-edge genomic science highly accessible, which it achieves through its investment in infrastructure, leveraging the best available technology, economies of scale, and expert bioinformatics resources. BGI, and its affiliates, BGI Americas, headquartered in Cambridge, MA, and BGI Europe, headquartered in Copenhagen, Denmark, have established partnerships and collaborations with leading academic and government research institutions as well as global biotechnology and pharmaceutical companies, supporting a variety of disease, agricultural, environmental, and related applications. BGI has a proven track record of excellence, delivering results with high efficiency and accuracy for innovative, high-profile research: research that has generated over 170 publications in top-tier journals such as Nature and Science. BGI's many accomplishments include: sequencing one percent of the human genome for the International Human Genome Project, contributing 10 percent to the International Human HapMap Project, carrying out research to combat SARS and German deadly E. coli, playing a key role in the Sino-British Chicken Genome Project, and completing the sequence of the rice genome, the silkworm genome, the first Asian diploid genome, the potato genome, and, more recently, have sequenced the human Gut Metagenome, and a significant proportion of the genomes for the1000 Genomes Project. For more information about BGI, please visit http://www.genomics.cn (http://www.genomics.cn). Contact Information: Bicheng Yang, Ph.D. Public Communication Officer BGI |